Anima Biotech

Anima Biotech is a privately held company located in Bernardsville, New Jersey. With 69 employees, Anima Biotech specializes in the intersection of mRNA biology and artificial intelligence. Anima Biotech develops the mRNA Lightning platform, a technology designed for the discovery of small molecule mRNA drugs and novel mRNA biology targets. This platform combines mRNA biology expertise with AI imaging technologies to visualize the entire life cycle of mRNA in cells and decode the mRNA biology underlying diseases. Through the analysis of millions of images from both healthy and diseased cells, Anima Biotech trains disease-specific mRNA image analysis neural networks to identify disease signatures, which are mRNA biology pathways that contribute to disease phenotypes. The company's mRNA Lightning platform utilizes a tera-scale mRNA biology lab to conduct high-content screening from a library of mRNA modulators. Images from this screening are then analyzed by the mRNA image neural network to identify active compounds that alter the mRNA biology signature. Anima Biotech's MOAi technology, an mRNA biology large language model, and the Lightning co-pilot work in tandem throughout the process to elucidate the mechanisms of action and molecular targets of these compounds. Anima Biotech's mRNA Lightning platform has been validated through strategic collaborations with pharmaceutical giants Lilly, Takeda, and AbbVie across various therapeutic areas. The company is currently advancing a pipeline of 20 drug discovery programs.